BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 22200056)

  • 1. Adsorption and release of biocides with mesoporous silica nanoparticles.
    Popat A; Liu J; Hu Q; Kennedy M; Peters B; Lu GQ; Qiao SZ
    Nanoscale; 2012 Feb; 4(3):970-5. PubMed ID: 22200056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan.
    Zhang Y; Zhi Z; Jiang T; Zhang J; Wang Z; Wang S
    J Control Release; 2010 Aug; 145(3):257-63. PubMed ID: 20450945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
    Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of size on the cellular endocytosis and controlled release of mesoporous silica nanoparticles for intracellular delivery.
    Gan Q; Dai D; Yuan Y; Qian J; Sha S; Shi J; Liu C
    Biomed Microdevices; 2012 Apr; 14(2):259-70. PubMed ID: 22124885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs.
    Jia L; Shen J; Li Z; Zhang D; Zhang Q; Duan C; Liu G; Zheng D; Liu Y; Tian X
    Int J Pharm; 2012 Dec; 439(1-2):81-91. PubMed ID: 23078857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A magnetic, reversible pH-responsive nanogated ensemble based on Fe3O4 nanoparticles-capped mesoporous silica.
    Gan Q; Lu X; Yuan Y; Qian J; Zhou H; Lu X; Shi J; Liu C
    Biomaterials; 2011 Mar; 32(7):1932-42. PubMed ID: 21131045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of pore size-tunable magnetic mesoporous silica nanoparticles.
    Zhang J; Li X; Rosenholm JM; Gu HC
    J Colloid Interface Sci; 2011 Sep; 361(1):16-24. PubMed ID: 21689824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme-responsive intracellular controlled release using nanometric silica mesoporous supports capped with "saccharides".
    Bernardos A; Mondragon L; Aznar E; Marcos MD; Martinez-Mañez R; Sancenon F; Soto J; Barat JM; Perez-Paya E; Guillem C; Amoros P
    ACS Nano; 2010 Nov; 4(11):6353-68. PubMed ID: 20958020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastable, redispersible, small, and highly organomodified mesoporous silica nanotherapeutics.
    Lin YS; Abadeer N; Hurley KR; Haynes CL
    J Am Chem Soc; 2011 Dec; 133(50):20444-57. PubMed ID: 22050408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of colloidal silica nanoparticles of a tunable mesopore size and their application to the adsorption of biomolecules.
    Fuertes AB; Valle-Vigón P; Sevilla M
    J Colloid Interface Sci; 2010 Sep; 349(1):173-80. PubMed ID: 20570275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic Fe3O4@mesoporous silica composites for drug delivery and bioadsorption.
    Huang S; Li C; Cheng Z; Fan Y; Yang P; Zhang C; Yang K; Lin J
    J Colloid Interface Sci; 2012 Jun; 376(1):312-21. PubMed ID: 22444483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isomer-dependent adsorption and release of cis- and trans-platin anticancer drugs by mesoporous silica nanoparticles.
    Tao Z; Xie Y; Goodisman J; Asefa T
    Langmuir; 2010 Jun; 26(11):8914-24. PubMed ID: 20148511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers.
    Popat A; Hartono SB; Stahr F; Liu J; Qiao SZ; Qing Max Lu G
    Nanoscale; 2011 Jul; 3(7):2801-18. PubMed ID: 21547299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release profile of insulin entrapped on mesoporous materials by freeze-thaw method.
    Tozuka Y; Sugiyama E; Takeuchi H
    Int J Pharm; 2010 Feb; 386(1-2):172-7. PubMed ID: 19931606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesoporous silica nanoparticles with redox-responsive surface linkers for charge-reversible loading and release of short oligonucleotides.
    Zhang J; Niemelä M; Westermarck J; Rosenholm JM
    Dalton Trans; 2014 Mar; 43(10):4115-26. PubMed ID: 24457531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton absorption in as-synthesized mesoporous silica nanoparticles as a structure-function relationship probing mechanism.
    Strømme M; Atluri R; Brohede U; Frenning G; Garcia-Bennett AE
    Langmuir; 2009 Apr; 25(8):4306-10. PubMed ID: 19281159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanostructure-loaded mesoporous silica for controlled release of coumarin derivatives: a novel testing of the hyperthermia effect.
    Al-Kady AS; Gaber M; Hussein MM; Ebeid el-ZM
    Eur J Pharm Biopharm; 2011 Jan; 77(1):66-74. PubMed ID: 20974253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges.
    Rosenholm JM; Sahlgren C; Lindén M
    Nanoscale; 2010 Oct; 2(10):1870-83. PubMed ID: 20730166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
    Lee JE; Lee N; Kim T; Kim J; Hyeon T
    Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated oxidation of epinephrine by silica nanoparticles.
    Tao Z; Wang G; Goodisman J; Asefa T
    Langmuir; 2009 Sep; 25(17):10183-8. PubMed ID: 19466813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.